Briggs Duncan W. Morrison
DirectorDr. Briggs Duncan W. Morrison, M.D., Ph.D., is Chair of the Board of Actithera, Inc. from September 2026. Dr. Morrison is a member of the board of directors of CRISPR Therapeutics. A medical oncologist with many years of experience in the pharmaceutical and biotechnology industries, he previously held executive leadership positions at Syndax Pharmaceuticals, AstraZeneca, Pfizer and Merck, where he oversaw the clinical development of numerous oncology medicines, including Tagrisso®, Imfinzi® and Lynparza®. Dr. Morrison was Chairman of Scientific Advisory Board of Transcenta Holding Limited. Dr. Morrison is Chairman of Arvinas, Inc. from February 12, 2026. Dr. Morrison is Lead Independent Director of Arvinas, Inc. from June 15, 2023. Dr. Morrison is Director of Werewolf Therapeutics, Inc. Dr. Morrison was Independent Director of Arvinas, Inc. until June 15, 2023. Dr. Morrison served as an Independent Director at Carisma Therapeutics, Inc. since March 7, 2023 until October 15, 2025. He is Independent Director of CRISPR Therapeutics AG from June 5, 2025. He is President, CEO & Director of Crossbow Therapeutics, Inc. He has served as Crossbow’s Chief Executive Officer and as a member of the Board of Directors since February 2022. He is trained as a medical oncologist and has been in the?biopharmaceutical industry for many years. He has overseen the clinical development from Phase 1 through to approval and life cycle management of many approved drugs, including Tagrisso®, Imfinzi® and Lynparza®. ?He serves on the Board of Directors of a number of public and private biotechnology companies and is an Executive Partner at MPM Capital.? He received his B.S. in?Biology from Georgetown University and his M.D. from the University of Connecticut.
Positions
- Company NameWerewolf Therapeutics, Inc.Stock CodeHOWLPositionDirectorColleagues
- DJDaniel J. HicklinFounder, CEO, President & Director
- LBLuke Basil EvninIndependent Chairman of the Board
- MJMichael J. UrbanChief Financial Officer
- JOJonathan OwenGeneral Counsel & Secretary
- MAMichael A. ShermanIndependent Director
- MCMeeta ChatterjeeIndependent Director
- BDBriggs Duncan W. MorrisonDirector
- Company NameArvinas, Inc.Stock CodeARVNPositionIndependent Chairman & Lead DirectorColleagues
- ARAndrew R. SaikCFO & Treasurer
- AMAngela M. CacaceChief Scientific Officer
- RTRandy TeelCEO, President & Director
- DKDavid K. LoomisVP & Chief Accounting Officer
- JBJeff BoyleVice President of Investor Relations
- ITIan TaylorChairman of Scientific Advisory Board
- EMEdward Moore KennedyIndependent Director
- LVLeslie V. NorwalkIndependent Director
